Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
67.1M
-
Number of holders
-
84
-
Total 13F shares, excl. options
-
36.3M
-
Shares change
-
-2.04M
-
Total reported value, excl. options
-
$155M
-
Value change
-
-$17.9M
-
Put/Call ratio
-
1.96
-
Number of buys
-
37
-
Number of sells
-
-50
-
Price
-
$4.26
Significant Holders of Olema Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (OLMA) as of Q1 2022
109 filings reported holding OLMA - Olema Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share as of Q1 2022.
Olema Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (OLMA) has 84 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.3M shares
of 67.1M outstanding shares and own 54.15% of the company stock.
Largest 10 shareholders include BVF INC/IL (7.41M shares), Logos Global Management LP (3.74M shares), JANUS HENDERSON GROUP PLC (3.56M shares), Fairmount Funds Management LLC (2.67M shares), BlackRock Inc. (2.55M shares), Cormorant Asset Management, LP (2.08M shares), Vivo Capital, LLC (1.69M shares), VANGUARD GROUP INC (1.39M shares), CITADEL ADVISORS LLC (1.26M shares), and WELLINGTON MANAGEMENT GROUP LLP (988K shares).
This table shows the top 84 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.